Scientists at the State Research Center Vector and the Novosibirsk Institute of Organic Chemistry of the Siberian Branch of the Russian Academy of Sciences have developed new camphor-based compounds that suppress orthopoxviruses, which include the monkeypox virus.
As reported TASS, citing the patent, the developers noted that the threat of orthopoxviruses remains in the world. At the same time, existing drugs are not sufficiently effective and have side effects. In addition, clinical efficacy is not always confirmed.
Russian scientists obtained 12 chemical compounds of camphor, and the derivatives were combined with acids using a reagent in a solvent. The yield of the useful substance ranged from 50 to 90%. The activity of the camphor derivatives was tested on African green monkey kidney cell culture against four poxviruses from the Vector Center collection. Among them were smallpox, cowpox and mousepox and viruses vaccinia. The tests showed that viruses were ultimately effectively suppressed.
Earlier, ViZh reported that a fourth case of monkeypox had been detected in the Moscow Region. Also in mid-October, the regional Health Ministry carried out anti-epidemic measures and temporarily isolated five people who had been in contact with another suspected carrier of the virus, but the diagnosis in this group was later ruled out.
ViZh reference
mpox is a relatively rare viral zoonotic disease. The most common route of transmission is close physical contact with a person who has symptoms of the disease. It is especially dangerous for people with weakened immunity. The infection is accompanied by fever, intoxication and enlarged lymph nodes, followed by the spread of a rash. First spots appear, then they turn into blisters. After they rupture, ulcers form, which heal with scab formation. When the scabs fall off, scars may remain. In mild cases, the disease usually resolves on its own and lasts from 14 to 21 days.



